UK becomes first country in the world to authorise a Crispr-based gene therapy


Treatment aims to cure patients with β-thalassaemia and sickle-cell disease

Ozempic needle injection

Weight-loss drug shortages prompt copycats and counterfeits


Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments

Pile of documents

UK Reach costs set to be slashed under government proposal

2023-11-14T13:41:00+00:00By Vanessa Zainzinger

Industry may need less hazard data to register chemicals under the regime

Gaussion team

Rapid-charging batteries with magnetic assistance

2023-11-06T09:33:00+00:00By Vanessa Zainzinger

UK spin-out Gaussion aims to charge electric vehicles in minutes


Three US juries side with cancer victims over Bayer on Roundup


Bayer unit Monsanto has lost its ‘winning streak’ of nine defence verdicts, and the company plans to appeal


Fatal explosion and fire at blending plant in Australia


One worker killed by incident at ACB Group in Melbourne

Teutopolis High School

US ammonia tanker spill kills five


Seven others hospitalised after traffic incident released 15,000 litres of anhydrous ammonia


Chemours is responsible for PFAS pollution, Dutch court rules


Interim decision holds DuPont spin-off liable for environmental damage caused by historical emissions from Dordrecht plant

Flu medicine

US regulator says phenylephrine is ineffective as a decongestant


FDA will begin consultation on removing the drug from hundreds of over-the-counter remedies